Andreas Busch - Net Worth and Insider Trading
Andreas Busch Net Worth
The estimated net worth of Andreas Busch is at least $42,280 dollars as of 2024-12-27. Andreas Busch is the Chief Innovation Officer of Cyclerion Therapeutics Inc and owns about 12,735 shares of Cyclerion Therapeutics Inc (CYCN) stock worth over $42,280. Details can be seen in Andreas Busch's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Andreas Busch has not made any transactions after 2020-11-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Andreas Busch
Andreas Busch Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Andreas Busch owns 2 companies in total, including Cyclerion Therapeutics Inc (CYCN) , and Absci Corp (ABSI) .
Click here to see the complete history of Andreas Busch’s form 4 insider trades.
Insider Ownership Summary of Andreas Busch
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2021-12-09 | Chief Scientific Officer |
| ABSI | Absci Corp | 2022-03-17 | director |
Andreas Busch Latest Holdings Summary
Andreas Busch currently owns a total of 1 stock. Andreas Busch owns 12,735 shares of Cyclerion Therapeutics Inc (CYCN) as of November 9, 2020, with a value of $42,280.
Latest Holdings of Andreas Busch
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYCN | Cyclerion Therapeutics Inc | 2020-11-09 | 12,735 | 3.32 | 42,280 |
Holding Weightings of Andreas Busch
Andreas Busch Form 4 Trading Tracker
According to the SEC Form 4 filings, Andreas Busch has made a total of 1 transactions in Cyclerion Therapeutics Inc (CYCN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Cyclerion Therapeutics Inc is the acquisition of 6,250 shares on November 9, 2020, which cost Andreas Busch around $316,250.
Insider Trading History of Andreas Busch
- 1
Andreas Busch Trading Performance
GuruFocus tracks the stock performance after each of Andreas Busch's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Andreas Busch is 107.64%. GuruFocus also compares Andreas Busch's trading performance to market benchmark return within the same time period. The performance of stocks bought by Andreas Busch within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Andreas Busch's insider trading performs compared to the benchmark.
Performance of Andreas Busch
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.75 | | | | | |
| Relative Return to S&P 500(%) | 14.25 | | | | | |
Andreas Busch Ownership Network
Andreas Busch Owned Company Details
What does Cyclerion Therapeutics Inc do?
Who are the key executives at Cyclerion Therapeutics Inc?
Andreas Busch is the Chief Scientific Officer of Cyclerion Therapeutics Inc. Other key executives at Cyclerion Therapeutics Inc include 10 percent owner Slate Path Capital Lp , director & Chief Executive Officer Peter M Hecht , and Chief Financial Officer Anjeza Gjino .
Cyclerion Therapeutics Inc (CYCN) Insider Trades Summary
Over the past 18 months, Andreas Busch made no insider transaction in Cyclerion Therapeutics Inc (CYCN). Other recent insider transactions involving Cyclerion Therapeutics Inc (CYCN) include a net sale of 357,880 shares made by Slate Path Capital Lp , and a net sale of 8 shares made by Terrance Mcguire .
In summary, during the past 3 months, insiders sold 357,880 shares of Cyclerion Therapeutics Inc (CYCN) in total and bought 0 shares, with a net sale of 357,880 shares. During the past 18 months, 357,888 shares of Cyclerion Therapeutics Inc (CYCN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 357,888 shares.
Cyclerion Therapeutics Inc (CYCN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cyclerion Therapeutics Inc Insider Transactions
Andreas Busch Mailing Address
Above is the net worth, insider trading, and ownership report for Andreas Busch. You might contact Andreas Busch via mailing address: C/o Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
